IS5829A - Peptide fragments of cholera toxin B or Iratatoxin B as vaccine adjuvants - Google Patents
Peptide fragments of cholera toxin B or Iratatoxin B as vaccine adjuvantsInfo
- Publication number
- IS5829A IS5829A IS5829A IS5829A IS5829A IS 5829 A IS5829 A IS 5829A IS 5829 A IS5829 A IS 5829A IS 5829 A IS5829 A IS 5829A IS 5829 A IS5829 A IS 5829A
- Authority
- IS
- Iceland
- Prior art keywords
- iratatoxin
- peptide fragments
- cholera toxin
- vaccine adjuvants
- vaccine
- Prior art date
Links
- 102000009016 Cholera Toxin Human genes 0.000 title 1
- 108010049048 Cholera Toxin Proteins 0.000 title 1
- 108010033276 Peptide Fragments Proteins 0.000 title 1
- 102000007079 Peptide Fragments Human genes 0.000 title 1
- 239000012646 vaccine adjuvant Substances 0.000 title 1
- 229940124931 vaccine adjuvant Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9819484.8A GB9819484D0 (en) | 1998-09-07 | 1998-09-07 | Therapeutic agents |
| PCT/GB1999/002970 WO2000014114A1 (en) | 1998-09-07 | 1999-09-07 | Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5829A true IS5829A (en) | 2001-03-07 |
Family
ID=10838466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5829A IS5829A (en) | 1998-09-07 | 2001-01-26 | Peptide fragments of cholera toxin B or Iratatoxin B as vaccine adjuvants |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1109828A1 (en) |
| JP (1) | JP2002524469A (en) |
| KR (1) | KR20010044842A (en) |
| CN (1) | CN1317013A (en) |
| AU (1) | AU772015B2 (en) |
| BR (1) | BR9913501A (en) |
| CA (1) | CA2338384A1 (en) |
| CZ (1) | CZ2001839A3 (en) |
| EA (1) | EA200100314A1 (en) |
| GB (2) | GB9819484D0 (en) |
| HU (1) | HUP0104090A2 (en) |
| IL (1) | IL141695A0 (en) |
| IS (1) | IS5829A (en) |
| MX (1) | MXPA01002387A (en) |
| NO (1) | NO20011075L (en) |
| NZ (1) | NZ509631A (en) |
| PL (1) | PL346549A1 (en) |
| WO (1) | WO2000014114A1 (en) |
| ZA (1) | ZA200100758B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010036917A1 (en) | 1995-07-05 | 2001-11-01 | Williams Neil Andrew | Therapeutic agents |
| GB9800487D0 (en) * | 1998-01-09 | 1998-03-04 | Oratol Limited | Therapies |
| GB0115382D0 (en) * | 2001-06-22 | 2001-08-15 | Univ Bristol | Mutant |
| WO2004047793A1 (en) | 2002-11-26 | 2004-06-10 | Alk-Abelló A/S | Pharmaceutical allergen product |
| CN104402974B (en) * | 2014-12-10 | 2017-11-14 | 重庆医科大学 | A kind of polypeptide with mucosal adjuvant activity and its purposes in mucosal adjuvant is prepared |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2527445A1 (en) * | 1982-05-26 | 1983-12-02 | Centre Nat Rech Scient | MEDICINAL PRODUCTS CONTAINING AT LEAST ONE SEQUENCE OF THE CHOLERIC TOXIN B1 SUBUNIT |
| IL69558A (en) * | 1983-08-23 | 1988-06-30 | Yeda Res & Dev | Synthetic cholera vaccine |
| ZA839512B (en) * | 1983-12-12 | 1984-08-29 | Scripps Clinic Res | Synthetic heat-stable enterotoxin polypeptide of escherichia coli and multimers thereof |
| FR2636842B1 (en) * | 1988-09-27 | 1994-06-10 | Liege Universite Etat | FUSION PROTEIN OF A SEQUENCE DERIVED FROM CHOLERIC TOXIN B SUBUNIT B AND A HETEROLOGOUS ANTIGEN HAVING IMMUNOGENIC PROPERTIES, RECOMBINANT NUCLEIC ACID CONTAINING VACCINE COMPOSITIONS CONTAINING NUCLEOTIDITE CODING SEQUENCE |
| WO1995020657A1 (en) * | 1994-01-27 | 1995-08-03 | Gx Biosystems A/S | Receptor specific bacterial adhesins and their use |
| IL109519A (en) * | 1994-05-03 | 1999-03-12 | Yeda Res & Dev | Vaccines for oral immunization against infecting agents |
| US6019982A (en) * | 1994-08-26 | 2000-02-01 | The Administrators Of The Tulane Educational Fund | Mutant enterotoxin effective as a non-toxic oral adjuvant |
-
1998
- 1998-09-07 GB GBGB9819484.8A patent/GB9819484D0/en not_active Ceased
-
1999
- 1999-09-07 EP EP99944696A patent/EP1109828A1/en not_active Withdrawn
- 1999-09-07 EA EA200100314A patent/EA200100314A1/en unknown
- 1999-09-07 WO PCT/GB1999/002970 patent/WO2000014114A1/en not_active Application Discontinuation
- 1999-09-07 CA CA002338384A patent/CA2338384A1/en not_active Abandoned
- 1999-09-07 CZ CZ2001839A patent/CZ2001839A3/en unknown
- 1999-09-07 KR KR1020017002217A patent/KR20010044842A/en not_active Application Discontinuation
- 1999-09-07 MX MXPA01002387A patent/MXPA01002387A/en unknown
- 1999-09-07 CN CN99810666A patent/CN1317013A/en active Pending
- 1999-09-07 IL IL14169599A patent/IL141695A0/en unknown
- 1999-09-07 BR BR9913501-9A patent/BR9913501A/en not_active IP Right Cessation
- 1999-09-07 PL PL99346549A patent/PL346549A1/en not_active Application Discontinuation
- 1999-09-07 AU AU57516/99A patent/AU772015B2/en not_active Ceased
- 1999-09-07 NZ NZ509631A patent/NZ509631A/en unknown
- 1999-09-07 JP JP2000568871A patent/JP2002524469A/en not_active Withdrawn
- 1999-09-07 GB GB0107375A patent/GB2357507A/en not_active Withdrawn
- 1999-09-07 HU HU0104090A patent/HUP0104090A2/en unknown
-
2001
- 2001-01-26 IS IS5829A patent/IS5829A/en unknown
- 2001-01-26 ZA ZA200100758A patent/ZA200100758B/en unknown
- 2001-03-02 NO NO20011075A patent/NO20011075L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL141695A0 (en) | 2002-03-10 |
| WO2000014114A1 (en) | 2000-03-16 |
| CN1317013A (en) | 2001-10-10 |
| EA200100314A1 (en) | 2001-10-22 |
| BR9913501A (en) | 2001-06-05 |
| JP2002524469A (en) | 2002-08-06 |
| GB2357507A (en) | 2001-06-27 |
| NZ509631A (en) | 2003-11-28 |
| HUP0104090A2 (en) | 2002-01-28 |
| ZA200100758B (en) | 2001-07-16 |
| AU5751699A (en) | 2000-03-27 |
| CA2338384A1 (en) | 2000-03-16 |
| NO20011075D0 (en) | 2001-03-02 |
| MXPA01002387A (en) | 2002-05-08 |
| NO20011075L (en) | 2001-05-07 |
| PL346549A1 (en) | 2002-02-11 |
| CZ2001839A3 (en) | 2001-08-15 |
| GB0107375D0 (en) | 2001-05-16 |
| KR20010044842A (en) | 2001-06-05 |
| AU772015B2 (en) | 2004-04-08 |
| EP1109828A1 (en) | 2001-06-27 |
| GB9819484D0 (en) | 1998-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300311I1 (en) | Adjuvant systems and vaccines | |
| NO20004758L (en) | vaccine Composition | |
| DE69933200D1 (en) | COMBINED VACCINE COMPOSITIONS | |
| NO2012018I1 (en) | Canakinumab or direct equivalents thereof | |
| CY2006004I2 (en) | METHOD FOR SEPARATION OF ROTAI VARIANTS AND LIVE ATTENUATED ROTAI VACCINE | |
| NO20003303L (en) | Vaccine | |
| IS4661A (en) | Inhaler device | |
| NO20006191D0 (en) | Vaccine | |
| AU2001277961A1 (en) | Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof | |
| DE69730092D1 (en) | Photocrosslinkable silicone compositions | |
| HUP0300099A3 (en) | Vaccine for the treatment of artherosclerosis | |
| IS6531A (en) | Methods for the preparation of clariodorphysin and clariodorphysin intermediates, essentially oxymorphic clariforomycin and preparations containing it | |
| DZ2283A1 (en) | Vaccine composition. | |
| DK0765333T3 (en) | Quillajasaponin adjuvant and vaccine formulation containing it | |
| DK1109574T3 (en) | Vaccine against sexually transmitted diseases | |
| IS5829A (en) | Peptide fragments of cholera toxin B or Iratatoxin B as vaccine adjuvants | |
| EP1276757A4 (en) | ANTIGENIC PEPTIDE FRAGMENTS OF VapA PROTEIN, AND USES THEREOF | |
| NO20005599L (en) | Vaccine | |
| DE69830156D1 (en) | COMPOSITIONS FOR IMMUNE IMPROVEMENT OF VACCINES | |
| EE200000694A (en) | Formulation of recombinant human iterferon beta-1a (IFN-β-1a) | |
| AU2001267613A1 (en) | Adjuvant composition comprising FHA protein or fragment of FHA protein in free form | |
| DE69930733D1 (en) | PREPARATION OF SUBSTITUTED (AMINO) ALKOXYSILANES | |
| DK1117421T3 (en) | New methods of therapeutic vaccination | |
| AU5203801A (en) | Antigenic peptide fragments of vapa protein, and uses thereof | |
| BR1100918A (en) | Vaccine composition containing adjuvants |